MedTrace Logo

Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPN

NCT05133947 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2023-04-03

No results posted yet for this study

Summary

This is a non-interventional study examining IENFD levels in patients with CIPN after taxane chemotherapy and in age-matched healthy subjects.

Conditions

  • Peripheral Nervous System Diseases

Interventions

OTHER

Non interventional

Non interventional

Sponsors & Collaborators

  • Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Xiaojiao Li · China

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-12
Primary Completion
2022-03-01
Completion
2022-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05133947 on ClinicalTrials.gov